| NCT04232956 |
Invasive Pulmonary Aspergillosis and Severe Influenza |
https://ClinicalTrials.gov/show/NCT04232956 |
Completed |
University Hospital, Brest |
2018-11-05 |
| NCT03339180 |
Cardiac Injury in Patients With Influenza |
https://ClinicalTrials.gov/show/NCT03339180 |
Recruiting |
Örebro University, Sweden |
2020-04-30 |
| NCT03278067 |
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England |
https://ClinicalTrials.gov/show/NCT03278067 |
Completed |
GlaxoSmithKline |
2017-11-30 |
| NCT03228095 |
Volatiles in Breath and Headspace Analysis - Diagnostic Markers |
https://ClinicalTrials.gov/show/NCT03228095 |
Enrolling by invitation |
University of Latvia |
2019-12-20 |
| NCT03196245 |
NK Cell Mediated Influenza Immunity During Pregnancy |
https://ClinicalTrials.gov/show/NCT03196245 |
Active, not recruiting |
Stanford University |
2020-08-01 |
| NCT03061955 |
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab) |
https://ClinicalTrials.gov/show/NCT03061955 |
Completed |
Advocate Health Care |
2017-03-31 |
| NCT03057483 |
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute |
https://ClinicalTrials.gov/show/NCT03057483 |
Completed |
Butantan Institute |
2017-09-06 |
| NCT03010410 |
Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS) |
https://ClinicalTrials.gov/show/NCT03010410 |
Enrolling by invitation |
Intermountain Health Care, Inc. |
2019-10-31 |
| NCT03010007 |
Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland |
https://ClinicalTrials.gov/show/NCT03010007 |
Completed |
University Hospital, Basel, Switzerland |
2018-05-31 |
| NCT03007797 |
Realization of the Recommendation for Influenza Vaccination in Pregnant Women |
https://ClinicalTrials.gov/show/NCT03007797 |
Completed |
University Hospital, Saarland |
2014-02-28 |
| NCT02984280 |
Specific Respiratory Infections as Triggers of Acute Medical Events |
https://ClinicalTrials.gov/show/NCT02984280 |
Completed |
University College, London |
2017-03-31 |
| NCT02983019 |
Treatment of Influenza in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT02983019 |
Completed |
Nearmedic Plus LLC |
2015-12-31 |
| NCT02979626 |
Evaluation of Moderate to Severe Influenza Outcomes in Children |
https://ClinicalTrials.gov/show/NCT02979626 |
Completed |
University of Colorado, Denver |
2018-05-04 |
| NCT02909855 |
Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine |
https://ClinicalTrials.gov/show/NCT02909855 |
Completed |
King’s College London |
2017-01-31 |
| NCT02900209 |
Influenza Vaccination and COPD Phenotypes |
https://ClinicalTrials.gov/show/NCT02900209 |
Completed |
University of Lincoln |
2017-09-30 |
| NCT02893878 |
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines |
https://ClinicalTrials.gov/show/NCT02893878 |
Completed |
GlaxoSmithKline |
2016-11-24 |
| NCT02885246 |
Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015 |
https://ClinicalTrials.gov/show/NCT02885246 |
Completed |
GlaxoSmithKline |
2018-09-17 |
| NCT02819180 |
Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB |
https://ClinicalTrials.gov/show/NCT02819180 |
Completed |
Butantan Institute |
2014-06-30 |
| NCT02819115 |
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT02819115 |
Completed |
Butantan Institute |
2013-07-31 |
| NCT02786381 |
Idylla IFV-RSV Panel Clinical Testing |
https://ClinicalTrials.gov/show/NCT02786381 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2016-10-31 |
| NCT02743676 |
A Retrospective, Observational Registry of Participants With Avian Influenza Infection |
https://ClinicalTrials.gov/show/NCT02743676 |
Completed |
Hoffmann-La Roche |
2012-03-31 |
| NCT02663102 |
Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines’ Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea. |
https://ClinicalTrials.gov/show/NCT02663102 |
Recruiting |
GlaxoSmithKline |
2021-12-01 |
| NCT02632578 |
Influenza Vaccine in HIV Study |
https://ClinicalTrials.gov/show/NCT02632578 |
Completed |
University of Melbourne |
2015-06-30 |
| NCT02600585 |
Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults |
https://ClinicalTrials.gov/show/NCT02600585 |
Completed |
Protein Sciences Corporation |
2016-09-30 |
| NCT02584036 |
Project IMPACT Immunizations (IMProving America’s Communities Together) |
https://ClinicalTrials.gov/show/NCT02584036 |
Completed |
American Pharmacists Association Foundation |
2016-04-30 |
| NCT02352389 |
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents |
https://ClinicalTrials.gov/show/NCT02352389 |
Recruiting |
St. Jude Children’s Research Hospital |
2020-08-31 |
| NCT02567721 |
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK) |
https://ClinicalTrials.gov/show/NCT02567721 |
Completed |
GlaxoSmithKline |
2015-11-30 |
| NCT01386424 |
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols |
https://ClinicalTrials.gov/show/NCT01386424 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02554409 |
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry |
https://ClinicalTrials.gov/show/NCT02554409 |
Completed |
Sanofi |
2019-04-30 |
| NCT03392207 |
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) |
https://ClinicalTrials.gov/show/NCT03392207 |
Completed |
Butantan Institute |
2018-07-17 |
| NCT02511002 |
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge |
https://ClinicalTrials.gov/show/NCT02511002 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2027-05-12 |
| NCT02459171 |
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers |
https://ClinicalTrials.gov/show/NCT02459171 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2024-03-31 |
| NCT02428738 |
Text Message Reminders for Influenza Vaccine in Pregnancy |
https://ClinicalTrials.gov/show/NCT02428738 |
Completed |
St. Michael’s Hospital, Toronto |
2014-01-31 |
| NCT02415842 |
A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals’ Pandemic Influenza Vaccines |
https://ClinicalTrials.gov/show/NCT02415842 |
Completed |
GlaxoSmithKline |
2018-02-16 |
| NCT02401893 |
Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults |
https://ClinicalTrials.gov/show/NCT02401893 |
Completed |
Vanderbilt University |
2010-07-31 |
| NCT02378090 |
A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico |
https://ClinicalTrials.gov/show/NCT02378090 |
Completed |
Mexican Emerging Infectious Diseases Clinical Research Network |
2016-11-30 |
| NCT02362919 |
Influenza Vaccination Among the Elderly Individuals |
https://ClinicalTrials.gov/show/NCT02362919 |
Completed |
Helmholtz Centre for Infection Research |
2016-05-31 |
| NCT02313740 |
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly |
https://ClinicalTrials.gov/show/NCT02313740 |
Completed |
Butantan Institute |
2015-06-30 |
| NCT02334514 |
The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection |
https://ClinicalTrials.gov/show/NCT02334514 |
Completed |
Rambam Health Care Campus |
2017-05-30 |
| NCT02302924 |
Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III |
https://ClinicalTrials.gov/show/NCT02302924 |
Completed |
Uniformed Services University of the Health Sciences |
2015-03-31 |
| NCT02142491 |
Clinical Tolerance to a Live Attenuated Vaccine Against Influenza (Flumist®) in a Population Allergic to Eggs |
https://ClinicalTrials.gov/show/NCT02142491 |
Completed |
St. Justine’s Hospital |
2014-02-28 |
| NCT02136017 |
Post-License Safety Evaluation of Influenza Virus Vaccine |
https://ClinicalTrials.gov/show/NCT02136017 |
Completed |
Sichuan Center for Disease Control and Prevention |
2013-12-31 |
| NCT02133456 |
A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older |
https://ClinicalTrials.gov/show/NCT02133456 |
Completed |
Centers for Disease Control and Prevention, China |
2014-03-31 |
| NCT02124096 |
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs |
https://ClinicalTrials.gov/show/NCT02124096 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-06-17 |
| NCT02067286 |
Detection of Influenza A, Influenza B, and RSV Using the Liatâ„¢ Assays on the Liatâ„¢ Analyzer |
https://ClinicalTrials.gov/show/NCT02067286 |
Completed |
IQuum, Inc. |
2015-04-30 |
| NCT01309568 |
“Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study” |
https://ClinicalTrials.gov/show/NCT01309568 |
Completed |
Quidel Corporation |
2011-04-30 |
| NCT01310374 |
Immune Response Study of Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT01310374 |
Completed |
Centers for Disease Control and Prevention, China |
2011-05-31 |
| NCT01302418 |
Collection and Testing of Respiratory Samples |
https://ClinicalTrials.gov/show/NCT01302418 |
Completed |
QIAGEN Gaithersburg, Inc |
2011-07-31 |
| NCT01298206 |
Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon |
https://ClinicalTrials.gov/show/NCT01298206 |
Completed |
St. Jude Children’s Research Hospital |
2013-06-30 |
| NCT01286142 |
Oseltamivir Infant Influenza Safety Study |
https://ClinicalTrials.gov/show/NCT01286142 |
Completed |
Charite University, Berlin, Germany |
2010-07-31 |
| NCT01282177 |
Influenza Vaccine Safety and Effectiveness in Healthcare Providers |
https://ClinicalTrials.gov/show/NCT01282177 |
Completed |
Dalhousie University |
2012-04-30 |
| NCT01271842 |
Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study |
https://ClinicalTrials.gov/show/NCT01271842 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
NA |
| NCT02019745 |
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers |
https://ClinicalTrials.gov/show/NCT02019745 |
Completed |
University of North Carolina, Chapel Hill |
2016-06-30 |
| NCT02019732 |
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States |
https://ClinicalTrials.gov/show/NCT02019732 |
Completed |
GlaxoSmithKline |
2013-06-30 |
| NCT01995851 |
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools |
https://ClinicalTrials.gov/show/NCT01995851 |
Completed |
Dalhousie University |
2014-01-31 |
| NCT01859039 |
Safety of Nasal Influenza Immunisation in Egg Allergic Children |
https://ClinicalTrials.gov/show/NCT01859039 |
Completed |
Imperial College London |
2014-02-28 |
| NCT01839760 |
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients |
https://ClinicalTrials.gov/show/NCT01839760 |
Completed |
Crucell Holland BV |
2014-01-31 |
| NCT01318876 |
Surveillance for Adverse Events Following Influenza Immunization |
https://ClinicalTrials.gov/show/NCT01318876 |
Completed |
PHAC/CIHR Influenza Research Network |
2011-02-28 |
| NCT01753531 |
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B |
https://ClinicalTrials.gov/show/NCT01753531 |
Completed |
Sekisui Diagnostics, LLC |
2013-04-30 |
| NCT01715792 |
Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrixâ„¢ in UK |
https://ClinicalTrials.gov/show/NCT01715792 |
Completed |
GlaxoSmithKline |
2013-08-31 |
| NCT01683630 |
Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada |
https://ClinicalTrials.gov/show/NCT01683630 |
Completed |
International Centre for Infectious Diseases, Canada |
2012-09-30 |
| NCT01599390 |
Influenza Burden Assessment in the United States, July1997 - up to April 2009 |
https://ClinicalTrials.gov/show/NCT01599390 |
Completed |
GlaxoSmithKline |
2013-02-28 |
| NCT01521416 |
Cost of Illness Associated With Influenza in the UK |
https://ClinicalTrials.gov/show/NCT01521416 |
Completed |
GlaxoSmithKline |
2013-04-30 |
| NCT01517191 |
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults |
https://ClinicalTrials.gov/show/NCT01517191 |
Completed |
Dalhousie University |
2016-12-31 |
| NCT01520935 |
Influenza Burden Assessment in the United Kingdom, 1996-2008 |
https://ClinicalTrials.gov/show/NCT01520935 |
Completed |
GlaxoSmithKline |
2012-05-31 |
| NCT01496079 |
Maternal Immunization: Giving Immunity For Tomorrow |
https://ClinicalTrials.gov/show/NCT01496079 |
Completed |
University of Utah |
2015-12-31 |
| NCT01484522 |
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth |
https://ClinicalTrials.gov/show/NCT01484522 |
Completed |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
2010-01-31 |
| NCT01462487 |
Safety of Inhaled Zanamivir in Pregnancy |
https://ClinicalTrials.gov/show/NCT01462487 |
Completed |
GlaxoSmithKline |
2012-08-31 |
| NCT01455753 |
The Effect of Proximity on Flu-Shot Participation |
https://ClinicalTrials.gov/show/NCT01455753 |
Completed |
National Bureau of Economic Research, Inc. |
2012-05-31 |
| NCT01418287 |
Characterization of Influenza-like Illness in Mexico |
https://ClinicalTrials.gov/show/NCT01418287 |
Completed |
Mexican Emerging Infectious Diseases Clinical Research Network |
2014-05-31 |
| NCT01416597 |
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains |
https://ClinicalTrials.gov/show/NCT01416597 |
Completed |
GlaxoSmithKline |
2011-12-31 |
| NCT01390792 |
Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis) |
https://ClinicalTrials.gov/show/NCT01390792 |
Completed |
GlaxoSmithKline |
2009-02-28 |
| NCT01381029 |
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals |
https://ClinicalTrials.gov/show/NCT01381029 |
Completed |
George Washington University |
2014-08-31 |
| NCT01769430 |
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza |
https://ClinicalTrials.gov/show/NCT01769430 |
Completed |
University of Maryland, College Park |
2013-03-31 |
| NCT04431050 |
Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens |
https://ClinicalTrials.gov/show/NCT04431050 |
Recruiting |
Imperial College London |
2021-04-30 |
| NCT04367883 |
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection |
https://ClinicalTrials.gov/show/NCT04367883 |
Recruiting |
Consorci Sanitari de Terrassa |
2020-07-30 |
| NCT04336020 |
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study |
https://ClinicalTrials.gov/show/NCT04336020 |
Recruiting |
Scripps Translational Science Institute |
2022-04-30 |
| NCT04313946 |
Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays |
https://ClinicalTrials.gov/show/NCT04313946 |
Recruiting |
Grigore T. Popa University of Medicine and Pharmacy |
2020-08-16 |
| NCT04245800 |
Home Testing of Respiratory Illness |
https://ClinicalTrials.gov/show/NCT04245800 |
Active, not recruiting |
Evidation Health |
2020-03-31 |
| NCT04282135 |
Detection of Influenza Infection by IMS of Nasal Air Sampling |
https://ClinicalTrials.gov/show/NCT04282135 |
Recruiting |
Klinikum Bayreuth GmbH |
2020-04-30 |
| NCT04244500 |
Burden of Influenza at Emergency Department (ED) Level in European Countries |
https://ClinicalTrials.gov/show/NCT04244500 |
Recruiting |
University of Rostock |
2020-04-30 |
| NCT04223544 |
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04223544 |
Recruiting |
Wroclaw Medical University |
2020-04-03 |
| NCT04172610 |
Prevalence of Influenza RelAted Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT04172610 |
Recruiting |
Karolinska University Hospital |
2020-04-30 |
| NCT04086628 |
Influenza Vaccine in Children With Asthma |
https://ClinicalTrials.gov/show/NCT04086628 |
Recruiting |
Central Hospital, Nancy, France |
2020-04-30 |
| NCT04077697 |
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study. |
https://ClinicalTrials.gov/show/NCT04077697 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2019-07-16 |
| NCT04038333 |
Financing Strategies of Influenza Vaccination in China |
https://ClinicalTrials.gov/show/NCT04038333 |
Recruiting |
Peking University |
2019-10-30 |
| NCT04008823 |
Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons |
https://ClinicalTrials.gov/show/NCT04008823 |
Completed |
Asociacion Instituto Biodonostia |
2017-11-02 |
| NCT03930017 |
Pregnancy, Arsenic and Immune Response |
https://ClinicalTrials.gov/show/NCT03930017 |
Enrolling by invitation |
Johns Hopkins Bloomberg School of Public Health |
2020-02-28 |
| NCT03884777 |
Incidence and Risk of Influenza in Myasthenic Patients |
https://ClinicalTrials.gov/show/NCT03884777 |
Completed |
Centre d’Investigation Clinique et Technologique 805 |
2017-12-31 |
| NCT03813966 |
Nasal Swab Home Collection Kit (NSHC Kit) Study |
https://ClinicalTrials.gov/show/NCT03813966 |
Active, not recruiting |
University of Wisconsin, Madison |
2020-03-04 |
| NCT03757546 |
Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus Infections |
https://ClinicalTrials.gov/show/NCT03757546 |
Completed |
Poitiers University Hospital |
2019-03-14 |
| NCT03748069 |
Influenza Associated Aspergillosis In-depth Investigation |
https://ClinicalTrials.gov/show/NCT03748069 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2021-04-30 |
| NCT03743688 |
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03743688 |
Completed |
Vanderbilt University Medical Center |
2019-07-26 |
| NCT03694392 |
Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years |
https://ClinicalTrials.gov/show/NCT03694392 |
Recruiting |
Kaiser Permanente |
2022-05-15 |
| NCT03599739 |
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey |
https://ClinicalTrials.gov/show/NCT03599739 |
Active, not recruiting |
Insight Therapeutics, LLC |
2019-02-15 |
| NCT03451656 |
Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel Basel |
https://ClinicalTrials.gov/show/NCT03451656 |
Completed |
University Hospital, Basel, Switzerland |
2017-04-30 |
| NCT03442582 |
Afluria Pregnancy Registry |
https://ClinicalTrials.gov/show/NCT03442582 |
Recruiting |
Seqirus |
2020-08-31 |
| NCT03417869 |
QuickVue Influenza A + B Test Field Study |
https://ClinicalTrials.gov/show/NCT03417869 |
Completed |
Quidel Corporation |
2018-02-01 |
| NCT03438487 |
Flucelvax (TIVc or QIVc) Pregnancy Registry |
https://ClinicalTrials.gov/show/NCT03438487 |
Active, not recruiting |
Seqirus |
2020-12-31 |
| NCT01262079 |
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S. |
https://ClinicalTrials.gov/show/NCT01262079 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-07-31 |
| NCT01254955 |
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients |
https://ClinicalTrials.gov/show/NCT01254955 |
Completed |
Sahlgrenska University Hospital, Sweden |
2011-01-31 |
| NCT01239537 |
Swine Flu (Influenza A H1N1) Follow on Vaccine Study |
https://ClinicalTrials.gov/show/NCT01239537 |
Completed |
University of Oxford |
2010-12-31 |
| NCT01218685 |
Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants |
https://ClinicalTrials.gov/show/NCT01218685 |
Completed |
Butantan Institute |
2010-09-30 |
| NCT01206114 |
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11 |
https://ClinicalTrials.gov/show/NCT01206114 |
Completed |
National Institute for Health and Welfare, Finland |
2011-04-30 |
| NCT01203527 |
A Study of the Pharmacology of Tamiflu in Pregnancy |
https://ClinicalTrials.gov/show/NCT01203527 |
Completed |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2012-10-31 |
| NCT01199744 |
Relenza® Sentinel Site Monitoring Program in Japan |
https://ClinicalTrials.gov/show/NCT01199744 |
Completed |
GlaxoSmithKline |
2009-11-30 |
| NCT01191853 |
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines |
https://ClinicalTrials.gov/show/NCT01191853 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01178918 |
Non-specific Response to H1N1 Vaccine |
https://ClinicalTrials.gov/show/NCT01178918 |
Completed |
The University Clinic of Pulmonary and Allergic Diseases Golnik |
2010-12-01 |
| NCT01156701 |
Prophylactic Efficacy of Relenza Against Influenza A and B |
https://ClinicalTrials.gov/show/NCT01156701 |
Completed |
GlaxoSmithKline |
2010-05-31 |
| NCT01150552 |
Studies of Avian Influenza Transmission to Humans in Egypt |
https://ClinicalTrials.gov/show/NCT01150552 |
Completed |
St. Jude Children’s Research Hospital |
2014-05-31 |
| NCT01136057 |
Blood and Plasma Collection For Use in Future Clinical Trials |
https://ClinicalTrials.gov/show/NCT01136057 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-01-04 |
| NCT01107262 |
Avian Influenza Studies In Lebanon |
https://ClinicalTrials.gov/show/NCT01107262 |
Completed |
St. Jude Children’s Research Hospital |
2010-12-31 |
| NCT01106196 |
The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER Study |
https://ClinicalTrials.gov/show/NCT01106196 |
Completed |
University College, London |
2012-10-31 |
| NCT01101074 |
Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine |
https://ClinicalTrials.gov/show/NCT01101074 |
Completed |
Novartis |
2010-01-31 |
| NCT01098786 |
Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine |
https://ClinicalTrials.gov/show/NCT01098786 |
Completed |
Novartis |
2010-11-30 |
| NCT01089816 |
Rapid Diagnostic Test for Influenza |
https://ClinicalTrials.gov/show/NCT01089816 |
Completed |
Meso Scale Diagnostics, LLC. |
2010-08-31 |
| NCT01089400 |
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage |
https://ClinicalTrials.gov/show/NCT01089400 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
NA |
| NCT01083511 |
Collection and Extraction of Respiratory Specimens |
https://ClinicalTrials.gov/show/NCT01083511 |
Completed |
QIAGEN Gaithersburg, Inc |
2010-05-31 |
| NCT01074736 |
Host Genetic Susceptibility to Avian Influenza A/H5N1 |
https://ClinicalTrials.gov/show/NCT01074736 |
Completed |
South East Asia Infectious Disease Clinical Research Network |
2010-08-31 |
| NCT01066169 |
Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza |
https://ClinicalTrials.gov/show/NCT01066169 |
Completed |
Leiden University Medical Center |
2010-02-28 |
| NCT01056354 |
Respiratory Virus Outpatient Study (FLU 002 Plus) |
https://ClinicalTrials.gov/show/NCT01056354 |
Completed |
University of Minnesota |
2017-05-12 |
| NCT01056185 |
Respiratory Virus Hospitalization Study (FLU 003 Plus) |
https://ClinicalTrials.gov/show/NCT01056185 |
Recruiting |
University of Minnesota |
2020-12-31 |
| NCT01046734 |
Virus Shedding and Environmental Deposition of a Novel Influenza Virus |
https://ClinicalTrials.gov/show/NCT01046734 |
Completed |
University of Nottingham |
2011-03-31 |
| NCT01046331 |
Novel Influenza A (H1N1) Surveillance Registry |
https://ClinicalTrials.gov/show/NCT01046331 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2010-04-30 |
| NCT01040741 |
Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine |
https://ClinicalTrials.gov/show/NCT01040741 |
Completed |
Novartis |
2011-03-31 |
| NCT01037855 |
Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine |
https://ClinicalTrials.gov/show/NCT01037855 |
Completed |
Novartis |
2010-06-30 |
| NCT01037829 |
Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study |
https://ClinicalTrials.gov/show/NCT01037829 |
Completed |
Novartis |
2010-11-30 |
| NCT01032980 |
Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults |
https://ClinicalTrials.gov/show/NCT01032980 |
Completed |
Sanofi |
2011-01-31 |
| NCT01024725 |
Evaluation of Pandemic Vaccination Campaign |
https://ClinicalTrials.gov/show/NCT01024725 |
Completed |
National Institute for Health and Welfare, Finland |
2010-04-30 |
| NCT01024673 |
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1) |
https://ClinicalTrials.gov/show/NCT01024673 |
Recruiting |
University of Pittsburgh |
2025-12-31 |
| NCT01011582 |
Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza |
https://ClinicalTrials.gov/show/NCT01011582 |
Completed |
Virginia Commonwealth University |
2010-06-30 |
| NCT00998803 |
Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults |
https://ClinicalTrials.gov/show/NCT00998803 |
Completed |
St. Jude Children’s Research Hospital |
2012-06-30 |
| NCT00996970 |
Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons |
https://ClinicalTrials.gov/show/NCT00996970 |
Active, not recruiting |
Uniformed Services University of the Health Sciences |
2009-12-31 |
| NCT00996853 |
Post-Authorization Safety Study of GSK Biologicals’ Pandemic Influenza Vaccine (H1N1) in the United Kingdom |
https://ClinicalTrials.gov/show/NCT00996853 |
Completed |
GlaxoSmithKline |
2010-10-20 |
| NCT00985582 |
Antiviral Therapy for Influenza A H1N1 |
https://ClinicalTrials.gov/show/NCT00985582 |
Completed |
South East Asia Infectious Disease Clinical Research Network |
2010-08-31 |
| NCT00984451 |
A Pilot Study for Collection of Anti-Influenza A Immune Plasma |
https://ClinicalTrials.gov/show/NCT00984451 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2018-12-31 |
| NCT00965354 |
Mechanisms of Severe Acute Influenza Consortium (MOSAIC) |
https://ClinicalTrials.gov/show/NCT00965354 |
Completed |
Imperial College London |
2011-02-28 |
| NCT00950456 |
Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT00950456 |
Completed |
Ology Bioservices |
2010-12-31 |
| NCT00884117 |
Influenza Resistance Information Study |
https://ClinicalTrials.gov/show/NCT00884117 |
Completed |
Hoffmann-La Roche |
2015-11-30 |
| NCT01192737 |
“COhort Study on A/H1N1 FLU During PREGnancy” |
https://ClinicalTrials.gov/show/NCT01192737 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2010-09-30 |
| NCT00828828 |
Antibody Response to Influenza Vaccine in Patients With Sarcoidosis |
https://ClinicalTrials.gov/show/NCT00828828 |
Completed |
Shahid Beheshti University of Medical Sciences |
2009-02-28 |
| NCT01584908 |
Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01584908 |
Completed |
University of Alberta |
2014-04-30 |
| NCT00533182 |
Influenza in People With Normal and Weakened Immune Systems |
https://ClinicalTrials.gov/show/NCT00533182 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02846311 |
Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV |
https://ClinicalTrials.gov/show/NCT02846311 |
Completed |
Groupe Hospitalier Paris Saint Joseph |
2015-04-30 |
| NCT00760500 |
Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China |
https://ClinicalTrials.gov/show/NCT00760500 |
Completed |
St. Jude Children’s Research Hospital |
2014-03-31 |
| NCT00677547 |
Cell-mediated Immune Response to Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT00677547 |
Completed |
University of Alberta |
2010-01-31 |
| NCT00636662 |
FLU A+B Nasal Swab Clinical Study |
https://ClinicalTrials.gov/show/NCT00636662 |
Completed |
Response Biomedical Corp. |
2008-05-31 |
| NCT00593970 |
Influenza Vaccine in Pregnancy Part 2 |
https://ClinicalTrials.gov/show/NCT00593970 |
Completed |
St. Michael’s Hospital, Toronto |
2013-10-31 |
| NCT00551837 |
Immune Response to Influenza Vaccination |
https://ClinicalTrials.gov/show/NCT00551837 |
Completed |
The Cleveland Clinic |
2008-04-30 |
| NCT00455169 |
Influenza Vaccine in Premature Infants |
https://ClinicalTrials.gov/show/NCT00455169 |
Completed |
University of Rochester |
2008-05-31 |
| NCT00448617 |
Cigarette Smoke and Susceptibility to Influenza Infection |
https://ClinicalTrials.gov/show/NCT00448617 |
Completed |
University of North Carolina, Chapel Hill |
2011-09-30 |
| NCT00428831 |
Clinical IGSP-CHOP Boston |
https://ClinicalTrials.gov/show/NCT00428831 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-09-30 |
| NCT00428753 |
China Case Control Avian Influenza |
https://ClinicalTrials.gov/show/NCT00428753 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00428493 |
Prospective Study of AI H5N1 in China |
https://ClinicalTrials.gov/show/NCT00428493 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00419861 |
Inpatient Influenza Surveillance |
https://ClinicalTrials.gov/show/NCT00419861 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-04-30 |
| NCT00421837 |
Pilot Study of Genotypic Analysis |
https://ClinicalTrials.gov/show/NCT00421837 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12-31 |
| NCT00401700 |
Influenza Vaccine Postpartum Questionnaire |
https://ClinicalTrials.gov/show/NCT00401700 |
Completed |
St. Michael’s Hospital, Toronto |
2008-01-31 |
| NCT00337896 |
T and B Cell Response to Avian Flu Vaccine |
https://ClinicalTrials.gov/show/NCT00337896 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-05-31 |
| NCT00311701 |
Chart Review of Antivirals for Influenza in Infants |
https://ClinicalTrials.gov/show/NCT00311701 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00306982 |
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarixâ„¢ |
https://ClinicalTrials.gov/show/NCT00306982 |
Completed |
GlaxoSmithKline |
2006-12-31 |
| NCT00265161 |
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting. |
https://ClinicalTrials.gov/show/NCT00265161 |
Completed |
HaEmek Medical Center, Israel |
NA |
| NCT00170482 |
Elderly Influenza Vaccine Immunogenicity Substudy |
https://ClinicalTrials.gov/show/NCT00170482 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-05-30 |
| NCT00542776 |
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT00542776 |
Completed |
Boston Children’s Hospital |
2008-02-29 |